605
Participants
Start Date
July 4, 2013
Primary Completion Date
March 20, 2014
Study Completion Date
March 20, 2014
Budesonide/Formoterol SPIROMAX®
BF Spiromax will be administered per dose and schedule specified in the arm.
SYMBICORT® TURBOHALER®
Symbicort Turbohaler will be administered per dose and schedule specified in the arm.
SYMBICORT placebo
SYMBICORT placebo multi-dose dry powder inhaler (DPI) identical in appearance to SYMBICORT TURBOHALER will be administered per dose and schedule specified in the arm.
SPIROMAX Placebo
SPIROMAX Placebo multi-dose dry powder inhaler (DPI) identical in appearance to BF SPIROMAX will be administered per dose and schedule specified in the arm.
Teva Investigational Site 51072, Budapest
Teva Investigational Site 51074, Törökbálint
Teva Investigational Site 51067, Budapest
Teva Investigational Site 39020, Copenhagen NV
Teva Investigational Site 51075, Balassagyarmat
Teva Investigational Site 51076, Tatabánya
Teva Investigational Site 51068, Komárom
Teva Investigational Site 37031, Halen
Teva Investigational Site 33019, Linz
Teva Investigational Site 32246, Leipzig
Teva Investigational Site 33018, Wels
Teva Investigational Site 33020, Grieskirchen
Teva Investigational Site 39021, Odense
Teva Investigational Site 37030, Jambes
Teva Investigational Site 37029, Gozée
Teva Investigational Site 51065, Deszk
Teva Investigational Site 51070, Mosdós
Teva Investigational Site 51071, Kaposvár
Teva Investigational Site 51073, Kaposvár
Teva Investigational Site 51077, Csorna
Teva Investigational Site 32243, Berlin
Teva Investigational Site 32255, Berlin
Teva Investigational Site 32256, Berlin
Teva Investigational Site 32244, Neukölln
Teva Investigational Site 32257, Berlin
Teva Investigational Site 32241, Rudersdorf
Teva Investigational Site 80036, Afula
Teva Investigational Site 40003, Turku
Teva Investigational Site 30056, Milan
Teva Investigational Site 32249, Hamburg
Teva Investigational Site 32259, Großhansdorf
Teva Investigational Site 32250, Reinfeld
Teva Investigational Site 54068, Neratovice
Teva Investigational Site 31058, Madrid
Teva Investigational Site 40002, Pori
Teva Investigational Site 31051, Alcorcón
Teva Investigational Site 35088, Brest
Teva Investigational Site 31056, Pamplona
Teva Investigational Site 80035, Haifa
Teva Investigational Site 40001, Tampere
Teva Investigational Site 30054, Padua
Teva Investigational Site 35089, La Bouëxière
Teva Investigational Site 40005, Jyväskylä
Teva Investigational Site 31055, Seville
Teva Investigational Site 35090, Nantes
Teva Investigational Site 80040, Kfar Saba
Teva Investigational Site 32254, Gelsenkirchen
Teva Investigational Site 31053, Bilbao
Teva Investigational Site 80039, Petah Tikva
Teva Investigational Site 35092, Mûrs-Erigné
Teva Investigational Site 30055, Cisanello Pisa
Teva Investigational Site 32251, Frankfurt am Main
Teva Investigational Site 32253, Frankfurt am Main
Teva Investigational Site 32258, Offenbach
Teva Investigational Site 32240, Neu-Isenburg
Teva Investigational Site 35091, Perpignan
Teva Investigational Site 35093, Lyon
Teva Investigational Site 32247, Weinheim
Teva Investigational Site 80041, Ẕerifin
Teva Investigational Site 80038, Rehovot
Teva Investigational Site 50177, Moscow
Teva Investigational Site 50174, Yaroslavl
Teva Investigational Site 50170, Vsevolozhsk
Teva Investigational Site 50178, Saint Petersburg
Teva Investigational Site 50175, Saint Petersburg
Teva Investigational Site 50171, Saint Petersburg
Teva Investigational Site 50172, Saratov
Teva Investigational Site 50179, Kazan'
Teva Investigational Site 50173, Tomsk
Teva Investigational Site 80037, Ramat Gan
Teva Investigational Site 54056, Brno
Teva Investigational Site 54061, Hradec Králové
Teva Investigational Site 54063, Ostrava - Marianske Hory
Teva Investigational Site 54065, Pilsen
Teva Investigational Site 54067, Prague
Teva Investigational Site 54058, Prague
Teva Investigational Site 54064, Rokycany
Teva Investigational Site 54059, Strakonice
Teva Investigational Site 40004, Helsinki
Teva Investigational Site 32252, Cottbus
Teva Investigational Site 38048, Alkmaar
Teva Investigational Site 38049, Leeuwarden
Teva Investigational Site 53114, Bialystok
Teva Investigational Site 53110, Bialystok
Teva Investigational Site 53117, Gdansk
Teva Investigational Site 53106, Gdansk
Teva Investigational Site 53109, Krakow
Teva Investigational Site 53111, Krakow
Teva Investigational Site 53100, Krakow
Teva Investigational Site 53107, Lodz
Teva Investigational Site 53102, Lublin
Teva Investigational Site 53116, Poznan
Teva Investigational Site 53119, Sopot
Teva Investigational Site 53103, Strzelce Opolskie
Teva Investigational Site 53104, Szczecin
Teva Investigational Site 53105, Tarnów
Teva Investigational Site 53120, Wroclaw
Teva Investigational Site 53099, Wroclaw
Teva Investigational Site 53115, Wroclaw
Teva Investigational Site 53113, Zabrze
Teva Investigational Site 53101, Zgierz
Teva Investigational Site 31054, Badalona
Teva Investigational Site 31052, Barcelona
Teva Investigational Site 31057, Barcelona
Teva Investigational Site 31061, Vitoria-Gasteiz
Teva Investigational Site 42014, Gothenburg
Teva Investigational Site 42011, Lund
Teva Investigational Site 42012, Stockholm
Teva Investigational Site 34024, Chesterfield
Teva Investigational Site 34026, Coventry
Teva Investigational Site 34022, Dundee
Teva Investigational Site 34027, East Sussex
Teva Investigational Site 34029, Lancashire
Teva Investigational Site 34028, London
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY